Clinical Study of the CO2RE Laser Device Performance for Vaginal Atrophy Treatments

This study is a Prospective clinical study to demonstrate the CO2RE laser device for safety and efficacy for Vaginal Atrophy. Up to a total of 60 healthy candidates, seeking vaginal treatment from the participating investigator will be enrolled at a participating study site. Subjects will receive three (3) CO2RE treatments. Each subject will be followed for additional 5 post treatment visits (FU visits) that will be conducted at: * One week post first treatment - 1wk FU ± 2 days (Safety). * 1 month post last treatment - 1m FU ± 2 weeks (efficacy \& Safety). * 3 months post last treatment - 3m FU ± 2 weeks (efficacy \& Safety). * 6 months post last treatment - 6m FU ± 2 weeks (efficacy \& Safety). * 12 months post last treatment - 12m FU ± 2 weeks (efficacy \& Safety).